[Pathogenetic-clinical problems of Lyme borreliosis].
In this article a short review of pathogenesis and clinical manifestations of Lyme disease is presented. As regards pathogenesis, attention was paid to the mosaic protein structure of the B. burgdorfieri spirochete, particularly of outer surface proteins (Osp) that influence the clinical course and diagnosis of the disease. The presence of various atypical spirochete forms: spheroplastic L (without cell walls), cystic, and granular "blebs" may lead to a chronic form of the disease and to a low efficacy of antibiotic therapy. An important part of the pathogenesis is epithelial damage, stimulating the production of inflammatory cytokines (mainly IL-1, TNF-alpha, IFN-gamma), adhesive molecules and acute-phase proteins. Moreover, in the course of the disease not only an impairment of phagocytosis and chemotaxis was found, but also B. burgdorfieri spirochete binding by antibodies into immunological complexes that may maintain chronic inflammation. In terms of the Asbrink classification, complaints predominating in the clinical picture of an early and late stage of the disease were presented, with an emphasis on neuroborreliosis.
Hermanowska-Szpakowicz
Teresa
T
Kliniki Chorób Zakaźnych i Neuroinfekcji, AM w Białymstoku.
Zajkowska
Joanna M
JM
Pancewicz
Sławomir A
SA
Kondrusik
Maciej
M
Grygorczuk
Sambor S
SS
Swierzbińska
Renata
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D025065:Borrelia burgdorferi; D057167:Claudins; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D007375:Interleukin-1 / Q000276:immunology; D008193:Lyme Disease / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000900:Anti-Bacterial Agents; C120453:CLDN11 protein, human; D057167:Claudins; D007375:Interleukin-1; D009419:Nerve Tissue Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma